1. Medtech Insight
  2. >>Business
  3. >>Deals

M&A Analysis: Feeble Start To 2017

 
• By Catherine Longworth

2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.

Merging Business Network-Business leaders in global agreement
• Source: Shutterstock

While December 2016 rounded off with a final flurry of M&A activity, deal-making shifted down a gear in the first month of the new year. A total of 12 medtech M&A transactions were announced and recorded on Medtech Insight's M&A Data Tracker in January 2017, a decline from the 18 acquisitions in January 2016 and two fewer than December 2016. (Also see " MNA Analysis: 2016 Begins With Small List Highlighted By IVD Blockbuster " - Medtech Insight, 3 February, 2016.)

It continues the year-on-year downward trend in M&A deal volume, with 26 acquisitions tracked in January 2015 and 32 acquisitions in January 2014.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Deals Shaping The Medtech And Diagnostics Industries, March 2025

 
• By Medtech Insight Team

An interactive look at medtech and diagnostics deals made during March 2025. Data courtesy of Biomedtracker.

Roar Of Eargo-hearX Merger Echoes Through US OTC Hearing Aid Market

 
• By Malcolm Spicer

The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.

Anglonordic 25: Women’s Health Needs Therapeutic Success To Encourage Wider Investment

 
• By Natasha Barrow

Health tech is at the forefront of the women's health sector, securing 38% of venture capital in 2024. However, panelists at the Anglonordic Life Science Conference held 3 April asserted that a successful therapeutic breakthrough is key to gaining investor confidence and accelerating venture capital.

More from Business